Abstract

Following surgery for gynecologic malignancies, almost 1 month of subcutaneous low-molecular-weight heparin is recommended to prevent venous

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call